Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening

被引:12
|
作者
Rohner, Eliane [1 ]
Edelman, Claire [2 ]
Sanusi, Busola [3 ]
Schmitt, John W. [2 ]
Baker, Anna [1 ]
Chesko, Kirsty [4 ]
Faherty, Brian [4 ]
Gregory, Sean M. [4 ]
Romocki, LaHoma S. [5 ]
Sivaraman, Vijay [6 ]
Nelson, Julie A. E. [7 ]
O'Connor, Siobhan [8 ]
Hudgens, Michael G. [3 ]
Knittel, Andrea K. [9 ]
Rahangdale, Lisa [9 ,10 ]
Smith, Jennifer S. [1 ,10 ]
机构
[1] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA
[2] Duke Univ, Sch Med, Dept Obstet & Gynecol, Durham, NC USA
[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27515 USA
[4] Becton Dickinson & Co, Sparks, MD USA
[5] North Carolina Cent Univ, Dept Publ Hlth Educ, Durham, NC USA
[6] North Carolina Cent Univ, Dept Biol & Biomed Sci, Durham, NC USA
[7] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA
[8] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA
[9] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA
[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
关键词
HUMAN-PAPILLOMAVIRUS INFECTION; RISK; SPECIMENS; WOMEN; POPULATION; CONCORDANCE; PREVENTION; COHORT;
D O I
10.1158/1055-9965.EPI-20-0674
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Primary high-risk human papillomavirus (hr-HPV) testing of self-collected cervico-vaginal swabs could increase cervical cancer screening coverage, although triage strategies are needed to reduce unnecessary colposcopies. We evaluated the use of extended hr-HPV genotyping of self-collected samples for cervical cancer screening. Methods: We recruited women ages 25-65 years at two colposcopy clinics in North Carolina between November 2016 and January 2019, and obtained self-collected cervico-vaginal samples, provider-collected cervical samples, and cervical biopsies from all enrolled women. Self- and provider-collected samples were tested for 14 hr-HPV genotypes using the Onclarity Assay (Becton Dickinson). We calculated hr-HPV genotype-specific prevalence and assessed agreement between results in self- and provider-collected samples. We ranked the hr-HPV genotypes according to their positive predictive value (PPV) for the detection of cervical intraepithelial neoplasia (CIN) grade 2 or higher (CIN2+). Results: A total of 314 women participated (median age, 36 years); 85 women (27%) had CIN2+. More women tested positive for any hr-HPV on self-collected (76%) than on provider-collected samples (70%; P = 0.009) with type-specific agreement ranging from substantial to almost perfect. HPV-16 was the most common genotype in self- collected (27%) and provider-collected samples (20%), and HPV-16 prevalence was higher in self- than provider-collected samples (P < 0.001). In self- and provider-collected samples, HPV-16 had the highest PPV for CIN2+ detection. Conclusions: Overall sensitivity for CIN2+ detection was similar for both sample types, but the higher HPV-16 prevalence in self-collected samples could result in increased colposcopy referral rates. Impact: Additional molecular markers might be helpful to improve the triage of women who are hr-HPV positive on self-collected samples.
引用
收藏
页码:2651 / 2661
页数:11
相关论文
共 50 条
  • [21] Comparison of detection rate of high risk HPV infection between self-collected HPV testing and clinician-collected HPV testing in cervical cancer screening
    Nutthachote, Pattiya
    Oranratanaphan, Shina
    Termrungruanglert, Wichai
    Triratanachat, Surang
    Chaiwongkot, Arkom
    Baedyananda, Fern
    Bhattarakosol, Parvapan
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2019, 58 (04): : 477 - 481
  • [22] Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
    Chua, Brandon
    Lim, Li Min
    Ng, Joseph Soon Yau
    Ma, Yan
    Wee, Hwee Lin
    Caro, J. Jaime
    CANCERS, 2023, 15 (06)
  • [23] Reply to: Comments on "Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening"
    Sahasrabuddhe, Vikrant V.
    Castle, Philip E.
    Schiffman, Mark
    Wentzensen, Nicolas
    Heckman-Stoddard, Brandy
    Arbyn, Marc
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (03) : 484 - 487
  • [24] Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
    Wei, Baojun
    Mei, Ping
    Huang, Shengkai
    Yu, Xueting
    Zhi, Tong
    Wang, Guojing
    Xu, Xiaotian
    Xiao, Lin
    Dong, Xin
    Cui, Wei
    VIROLOGY JOURNAL, 2020, 17 (01)
  • [25] Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
    Baojun Wei
    Ping Mei
    Shengkai Huang
    Xueting Yu
    Tong Zhi
    Guojing Wang
    Xiaotian Xu
    Lin Xiao
    Xin Dong
    Wei Cui
    Virology Journal, 17
  • [26] Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol
    Reisner, Sari L.
    Deutsch, Madeline B.
    Peitzmeier, Sarah M.
    Hughto, Jaclyn M. White
    Cavanaugh, Timothy
    Pardee, Dana J.
    McLean, Sarah
    Marrow, Elliot J.
    Mimiaga, Matthew J.
    Panther, Lori
    Gelman, Marcy
    Green, Jamison
    Potter, Jennifer
    BMC INFECTIOUS DISEASES, 2017, 17
  • [27] Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol
    Sari L. Reisner
    Madeline B. Deutsch
    Sarah M. Peitzmeier
    Jaclyn M. White Hughto
    Timothy Cavanaugh
    Dana J. Pardee
    Sarah McLean
    Elliot J. Marrow
    Matthew J. Mimiaga
    Lori Panther
    Marcy Gelman
    Jamison Green
    Jennifer Potter
    BMC Infectious Diseases, 17
  • [28] Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay?
    Solnaes, Jannie Villekjaer
    Njor, Sisse Helle
    Tranberg, Mette
    BMC WOMENS HEALTH, 2023, 23 (01)
  • [29] Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay?
    Jannie Villekjær Solnæs
    Sisse Helle Njor
    Mette Tranberg
    BMC Women's Health, 23
  • [30] COST-MINIMIZATION ANALYSIS OF HPV 16/18 GENOTYPING TEST VERSUS HPV REFLEX GENOTYPING FOR CERVICAL CANCER SCREENING
    Skroumpelos, A.
    Agorastos, T.
    Chatzistamatiou, K.
    Poulios, N.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2017, 20 (09) : A588 - A588